Company Information

Business Description

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac®, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vac is approved for use in Israel and 14 other countries. VBI’s eVLP Platform technology allows for the development of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus (“CMV”) and glioblastoma multiforme (“GBM”). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel. Learn more about VBI Vaccines >>

Corporate Presentation

IR Contacts

Investor Relations
Nell Beattie
Telephone: (617) 830-3031

U.S. Legal Council
Mitchell Silberberg & Knupp LLP
12 East 49th Street, 30th Floor
New York, NY 10017

Canadian Legal Council
Borden Ladner Gervais LLP
1200 Waterfront Centre
Vancouver, British Columbia

Peterson Sullivan LLP
601 Union Street, #2300
Seattle, WA 98101
Telephone: (206) 382-7777

Transfer Agent
Equity Stock Transfer
237 West 37th Street, #601
New York, NY 10018
Telephone: (212) 575-5757

Industry Classifications


Vaccines Development

325414 Vaccines (i.e., bacterial, virus) manufacturing

2836 Biologics Products, except diagnostics substances

Frequently Asked Questions

What is VBI’s stock symbol?
Our stock is traded on the NASDAQ under the symbol VBIV.

Can I buy stock directly from VBI?
No, you will need to contact a licensed stock broker or use an online trading account.

How can I buy stock in VBI?
Through a licensed stock broker or by using an online trading account.

How do I change the address on my shareholder account?
Through your brokerage account or by contacting our transfer agent.

When was VBI incorporated?
Variation Biotechnologies Inc. was federally incorporated in Canada on August 24, 2001; Variation Biotechnologies (US), Inc.  was incorporated in Delaware on December 18, 2006.

Where is VBI located?
Our Corporate Headquarters is located in Cambridge, MA 02142, USA and our Research Operations are based in Ottawa, Ontario, Canada.

When is VBI’s fiscal year end?
December 31st.

Who is VBI’s transfer agent?
Equity Transfer Services, LLC.

Who are VBI’s independent auditors?
Peterson Sullivan LLP.

Who is VBI’s outside legal counsel?
Mitchell Silberberg & Knupp LLP.

Whom can I contact for general information about VBI?
Email us at